Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, National, Multicenter, Randomized, Double-blind, Double-masked, Compare the Efficacy of Ketoprofen, Cyclobenzaprine and Caffeine Association Versus Cyclobenzaprine and Caffeine (Miosan Caf®) in the Treatment of Osteomuscular Pain in Adults

NCT02862977 is registered in ClinicalTrials.gov with EMS as lead sponsor.

NCT NCT02862977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02862977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, National, Multicenter, Randomized, Double-blind, Double-masked, Compare the Efficacy of Ketoprofen, Cyclobenzaprine and Caffeine Association Versus Cyclobenzaprine and Caffeine (Miosan Caf®) in the Treatment of Osteomuscular Pain in Adults
Lead sponsor
EMS
Phase
Phase 3
Overall status
Completed
Start date
November 10, 2017
Completion date
December 20, 2019
Enrollment
414 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

musculoskeletal pain